UNSPSC 85816229: Introduction of immunostimulator into peripheral vein, open approach

This classification denotes the group of activities that yields a administrative intervention or procedure to introduction of immunostimulator into peripheral vein, open approach. This administrative intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 3E030WK

UNSPSC 85816229 Introduction of immunostimulator into peripheral vein, open approach is a Commodity code with virtually no recent state and local procurement activity aligned to its clinical scope. The code nominally describes a specific medical procedure—intravenous administration of immunostimulating agents—but the recent opportunities tagged under this code show little relevance to that work. Instead, the opportunites cover a broad range of health services procurement: telehealth urgent care platforms, general medical services contracting, comprehensive elderly care programs, cancer screening, occupational health evaluations, emergency medical services staffing, behavioral health treatment, recovery services, and administrative health infrastructure. None of these solicitations calls for the supply, delivery, or administration of intravenous immunostimulators as a discrete product or service line.

The recent activity in the block spans multiple states and issuing-body types—health plans, state departments, counties, cities, and special-purpose districts—without geographic or organizational concentration. The Nevada Health Authority appears twice with two separate RFPs (Program of All Inclusive Care for the Elderly, and Rural Value Acceleration Network Vendor), and San Mateo County appears twice as well (Cancer Registry Services and Handheld Retinal Screening Devices). Beyond those, activity is scattered across California, Georgia, Colorado, Nevada, Florida, Texas, Kansas, New Mexico, Missouri, Oregon, Illinois, Minnesota, and the District of Columbia. The code shows no recent state or local solicitations actually seeking immunostimulator products, equipment, or clinical administration services, suggesting either a data-tagging mismatch or minimal current demand for this specific commodity in the state and local market.